| Article | Added |
|---|
| NORD Calls Senate Bill Most Important Since Orphan Drug Act | 05-24-12 |
| Pharmaceutical Industry Labor Management Association (PILMA) Applauds Senate's Passage of S.3187 | 05-24-12 |
| American Society of Hematology Statement on Senate Passage of Prescription Drug User Fee Act (PDUFA) | 05-24-12 |
| Watson Confirms Testim® Patent Challenge | 05-24-12 |
| SRS Endoscopic System Receives FDA Clearance for Treatment of Gastroesophageal Reflux Disease (GERD) | 05-24-12 |
| The Horn Company To Be Vertellus Authorized Distributor | 05-24-12 |
| CVS Caremark Sponsored Research Finds Targeted Adherence Interventions to be More Effective than Broad Adherence Education | 05-24-12 |
| New Zoning to Highlight High-Growth Sectors at China Pharma Events | 05-23-12 |
| CPhI South America será ponto de encontro de grandes marcas mundiais de insumos farmacêuticos | 05-23-12 |
| CPhI South America será punto de encuentro de grandes marcas mundiales de insumos farmacéuticos | 05-23-12 |
| ECI and TalentFirst merge to form a Talent Management powerhouse! | 05-23-12 |
| Akrimax Pharmaceuticals announced the launch of Suprenza (phentermine HCl) orally disintegrating tablets (ODT) for the management of exogenous obesity | 05-23-12 |
| Endo Health Solutions Inc. Announced as New Name for Endo Pharmaceuticals Holdings Inc. | 05-23-12 |
| New Drug Application for Regorafenib for the Treatment of Metastatic Colorectal Cancer Submitted by Bayer | 05-23-12 |
| Anatabloc® Retail Expansion with GNC Complete: Product Now Available at all GNC Corporate Stores and GNC.com | 05-23-12 |
| QRxPharma Granted Additional US Patent on MoxDuo® | 05-23-12 |
| CVS Caremark Sponsored Research Finds FDA Drug Warnings Can Have Immediate Negative Impact on Medication Adherence, Even if Not Related to Safety | 05-23-12 |
| Webcast Alert: Isis Pharmaceuticals Hosts Dr. Sotirios Tsimikas to Review KYNAMRO? data Presented at the European Atherosclerosis Society 2012 Meeting | 05-23-12 |
| MicuRx Pharmaceuticals Announces Issuance Of U.S. Patent For Its Next-Generation Antibacterial Agent | 05-23-12 |
| Le nouveau rapport 2012 sur la chaîne du froid examine l'étendue des variations de températures lors de la manipulation des marchandises pharmaceutiques sensibles aux températures | 05-23-12 |
| Der neue Cold Chain-Bericht für 2012 untersucht das Ausmaß von kurzzeitigen Übertemperaturen beim Versand von temperaturempfindlichen Pharmaprodukten | 05-23-12 |
| New 2012 Cold Chain Report Examines the Extent of Temperature Excursions During the Handling of Temperature-Sensitive Pharmaceutical Shipments | 05-23-12 |
| Jim DuCharme Joins Prime Therapeutics as Chief Financial Officer | 05-22-12 |
| Medical Marijuana Inc. (MJNA) Corporate Update on Industry Company Services and Future Development. First Audio-Webcast Interview With SmallCapVoice.com in Quarterly Series | 05-22-12 |
| MusclePharm Signs Pro Baseball Rookie Phenom Bryce Harper As Sponsored Athlete | 05-22-12 |
| David F. Harty Joins Systech International as Vice President | 05-22-12 |
| Judge Upholds $3.3 Million Judgment In Favor of Fox Insurance Company Against Former Pharmacy Benefit Manager | 05-22-12 |
| Gentech Pharmaceutical Appoints New Medical Director for PhenTabz/ADDTabz | 05-22-12 |
| Valeritas Inc. Selects dLife's New Diabetes Patient Engagement Solution For Valeritas' V-go Disposable Insulin Delivery Device | 05-22-12 |
| U.S. Government Supports Phase 3 Study of Bavarian Nordic's Smallpox Vaccine | 05-22-12 |
| Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting | 05-22-12 |
| HealthWarehouse.com Offers Consumers the Lowest Price on Generic Plavix® | 05-22-12 |
| Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association | 05-22-12 |
| Phase 3 MISSION trial of Nexavar (sorafenib) in Patients with Non-Small Cell Lung Cancer Did Not Meet Primary Endpoint of Improving Overall Survival | 05-22-12 |
| Genpact Signs Business Process Management Engagement with Dr. Reddy's Laboratories | 05-22-12 |
| MorphoSys and Xencor Complete Enrollment in MOR208 (Xmab5574) Phase 1 Trial in CLL | 05-22-12 |
| 1.000er Teilnehmer in wegweisende Studie zum Thema Schlafstörungen und Herzfehler aufgenommen | 05-21-12 |
| Une étude décisive sur l'apnée du sommeil associée à l'insuffisance cardiaque recrute son 1 000e participant | 05-21-12 |
| Study Results of Novocure's NovoTTF? Pivotal Phase 3 Trial Published in European Journal of Cancer | 05-21-12 |
| Health Robotics' i.v.STATION Robot Receives Prestigious INDUSTRIESPREIS 2012 Award for Medical Devices | 05-21-12 |
| PneumRx, Inc. acquiert les actifs clés de Broncus | 05-21-12 |
| PneumRx, Inc. adquiere los principales activos de Broncus | 05-21-12 |
| PneumRx, Inc. Adquire Importantes Ativos da Broncus | 05-21-12 |
| Aushon steht vor Einführung einer neuen Plattform für Multiplex-Immunoassays | 05-21-12 |
| Lancement d'une nouvelle plate-forme d'immuno-essai par Aushon | 05-21-12 |
| Aushon to Launch New Multiplex Immunoassay Platform | 05-21-12 |
| PneumRx, Inc. adquiere activos clave de Broncus | 05-21-12 |
| Unigene to Present at TIDES 2012 | 05-21-12 |
| BioDelivery Sciences Receives $2.5 Million Milestone from Meda for BREAKYL in E.U. | 05-21-12 |
| PneumRx, Inc. Acquires Key Assets From Broncus | 05-21-12 |
| Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012 | 05-21-12 |
| Gary Lineker, Jayne Torvill and Other Celebrities Back 'Team Give Blood' Campaign | 05-21-12 |
| Landmark Sleep Apnea, Heart Failure Study Recruits 1,000th Participant | 05-21-12 |
| PneumRx, Inc. erwirbt bedeutende Aktivposten von Broncus | 05-21-12 |
| First, do no harm: Study finds danger in standard treatment for a serious lung disease | 05-20-12 |
| Medical Device Developers - Network at MD&M East Next Week | 05-18-12 |
| Perrigo Announces FDA Final Approval and Launch of Store Brand OTC Lansoprazole 15mg Capsules | 05-18-12 |
| Digestive Care, Inc. Announces FDA Approval of PERTZYE? (pancrelipase) Delayed-Release Capsules | 05-18-12 |
| Boston Scientific annonce les resultats positifs de l'etude clinique menee sur la valve aortique percutanee Lotus(TM) | 05-18-12 |
| Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets) | 05-18-12 |
| Purdue Pharma L.P. To Present Analysis Of Butrans® (buprenorphine) Transdermal System CIII Clinical Data At American Pain Society Annual Meeting | 05-18-12 |
| Watson Confirms Lo Loestrin® Fe Patent Challenge | 05-18-12 |
| UCB Proudly Reinforces Long-Standing Commitment to Crohn's Disease Community at Digestive Disease Week 2012 | 05-18-12 |
| Mylan Sponsors Drug Store News and Pharmacist Society to Provide a New Business Networking Platform for Pharmacy Schools and Students | 05-18-12 |
| ZYTIGA® (abiraterone acetate) Data to be Presented at 2012 American Society of Clinical Oncology (ASCO) Annual Meeting | 05-18-12 |
| Serono Symposia International Foundation bringt Experten zur CME-Jahrestagung für Multiple Sklerose 2012 nach Valencia | 05-18-12 |
| Serono Symposia International Foundation rassemble des experts à Valence pour la réunion annuelle 2012 de la CME sur la sclérose en plaques | 05-18-12 |
| Serono Symposia International Foundation reúne a expertos en Valencia para el congreso anual de CME 2012 sobre esclerosis múltiple | 05-18-12 |
| Pharmos Corporation Announces Successful Completion Of Proof-of-concept Clinical Trial Of Levotofisopam For The Treatment Of Gout | 05-17-12 |
| Road Show CPhI en Chile presenta el principal evento de ingredientes y servicios para la industria farmacéutica de América Latina | 05-17-12 |
| Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN) | 05-17-12 |
| Pharmaceutical Industry Labor-Management Association (PILMA) Statement on Prescription Drug User Fee Act (PDUFA) | 05-17-12 |
| Road Show CPhI no Chile apresenta o principal evento de ingredientes e serviços para indústria farmacêutica da América Latina | 05-17-12 |
| Large-Scale Meta-Analysis Shows Age Not a Social Barrier to Opioid Use and Misuse | 05-17-12 |
| Rural Health-Systems Benefit From Remote Pharmacy Technician Supervision | 05-17-12 |
| Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine | 05-17-12 |
| China BCT Reports First Quarter 2012 Results | 05-17-12 |
| Le Groupe travaillant sur la sécurité des patients renouvelle son appel pour une action urgente visant à protéger les patients contre les préjudices | 05-17-12 |
| New Data from Silence's Atu027 Anticancer Trial Published at ASCO | 05-17-12 |
| Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012 | 05-16-12 |
| Children with Cancer Have Complete Responses in a Children's Oncology Group Phase 1 Trial | 05-16-12 |
| Analysis Of Rilotumumab (AMG 102) Data Identifies A Potential Predictive Biomarker For Patients With Gastric Or Gastroesophageal Cancer | 05-16-12 |
| Amgen's BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia | 05-16-12 |
| Global Webinar Focuses on Considerations for Extractables and Leachables | 05-16-12 |
| Veeva Systems annuncia una eccezionale crescita in Europa | 05-16-12 |
| The Illinois Back Institute Helps Patient Beat Debilitating Back Pain | 05-16-12 |
| Armando Anido Joins Respira Therapeutics, Inc. Board of Directors | 05-16-12 |
| Access Alliance Proudly Supports the National Association of Police Organizations (NAPO) 2012 TOP COPS Awards® in Washington, DC | 05-16-12 |
| Folic Acid Essential For Prenatal Health, No Matter The Form | 05-16-12 |
| Generic Plavix® to Arrive at All Walmart and Sam's Club Pharmacies on May 19 | 05-16-12 |
| Global Cell-Based Assays Industry | 05-16-12 |
| 48th Annual Meeting of the American Society of Clinical Oncology (ASCO): Bayer to Present Data on Late-Stage Oncology Compounds at ASCO 2012 | 05-16-12 |
| Onyx Pharmaceuticals Announces Data Presentations at 48th American Society of Clinical Oncology Annual Meeting | 05-16-12 |
| ULURU Inc. Reports First Quarter 2012 Financial Results | 05-16-12 |
| Elevation Pharmaceuticals Announces Positive Phase 2b Results for EP-101 for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) | 05-16-12 |
| The Female Health Company to Present At B. Riley & Co. 13th Annual Investor Conference | 05-16-12 |
| Millennium Laboratories Sponsors Symposium on Managing Risk and Optimizing | 05-16-12 |
| Abbott Launches PediaSure SideKicks® Clear for Picky Eaters | 05-16-12 |
| Cardium Reports New Catheter-Based Methods Significantly Boost Cardiac Gene Delivery In Late-Breaking Presentation at 2012 American Society of Gene & Cell Therapy Meeting | 05-16-12 |
| CVS Caremark Focus on Medication Adherence Saves PBM Clients Nearly $2.4 Billion in 2011 | 05-16-12 |
| GP Strategies to Attend 13th Annual B. Riley & Co. Investor Conference | 05-16-12 |
| Heska to Present at B. Riley Investor Conference | 05-16-12 |
| Global Pharmaceutical Contract Manufacturing Industry | 05-16-12 |
| Patient Safety Technologies Reports First Quarter 2012 Results | 05-16-12 |
| Global Human Vaccines Industry | 05-16-12 |
| Inovio Pharmaceuticals' Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial | 05-16-12 |
| Medical Marijuana, Inc. Announces First Quarter 2012 Results | 05-15-12 |
| PLZ Aeroscience Acquires Assured Packaging | 05-15-12 |
| Attendees Save up to $350 on CHI Conferences This Summer by Registering Through Global Information | 05-15-12 |
| Contract Research Organizations Set to Experience Rapid Growth as Development Costs for New Drugs Continue to Rise | 05-15-12 |
| EnerJel? Adds 200 Independent Pharmacies To Distribution Base | 05-15-12 |
| Boston Scientific gibt positive Daten von einer Studie zum Transkatheter Aortenklappen-System Lotus? bekannt | 05-15-12 |
| Boston Scientific annuncia i risultati positivi dello studio sulla valvola aortica transcatere, Lotus? | 05-15-12 |
| Groundbreaking Alzheimer's Disease Prevention Trial Announced | 05-15-12 |
| PneumRx, Inc. recibe aprobación de la FDA para comenzar un ensayo clínico decisivo para el registro del sistema de bobina de reducción del volumen pulmonar RePneu (RePneu LVRC) | 05-15-12 |
| PneumRx, Inc. erhält Genehmigung der FDA für den Beginn der klinischen Zulassungsstudie des RePneu Lungenvolumenreduktionsspulen- (RePneu LVRC) Systems | 05-15-12 |
| INTAC? Technology Combats Misuse of Extended Release Drugs | 05-15-12 |
| Cardium Announces Agreement With UK-Based Angel Biomedical For Excellagen Supply And Planned European Market Expansion | 05-15-12 |
| Medicalbillersandcoders.com the Market Leader in Placing Certified Medical Coders in New Mexico | 05-15-12 |
| PneumRx, Inc. recebe aprovação da FDA para iniciar ensaio clínico pivot do Sistema RePneu de mola para redução volumétrica pulmonar (RePneu LVRC) | 05-15-12 |
| TPI Reports Third Quarter Fiscal Year 2012 Financial Results | 05-15-12 |
| Abbott's XIENCE PRIME? and XIENCE V® Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy | 05-15-12 |
| Pernix Therapeutics Introduces Omeclamox-Pak®, First Product in Gastroenterology Portfolio | 05-15-12 |
| Cardinal Health Brings Resolution to Litigation with DEA Settlement | 05-15-12 |
| Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic | 05-15-12 |
| Osteoporosis Drug Market- Global And China Market Analysis, Size, Trends And Forecast (2010-2015) | 05-15-12 |
| LifeLearn wins awards for three multimedia education programs | 05-15-12 |
| Global Pharmaceutical Survey 2012-2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry | 05-15-12 |
| Global Pharmaceutical Survey 2012-2013: Market Trends, Marketing Spend and Sales Strategies in the Global Pharmaceutical Industry | 05-15-12 |
| China Pharma Holdings, Inc. Reports First Quarter 2012 Financial Results | 05-15-12 |
| Sinovac Reports Unaudited First Quarter 2012 Financial Results | 05-15-12 |
| Adamas Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Arimenda? | 05-15-12 |
| EntreMed Reports First Quarter 2012 Financial Results | 05-15-12 |
| CutisPharma Homogeneity and Stability Study for Mouthwash Compounding Kits Presented at NERDG Meeting | 05-15-12 |
| PneumRx, Inc. Receives FDA Approval to Commence Pivotal Clinical Trial of RePneu Lung Volume Reduction Coil (RePneu LVRC) System | 05-15-12 |
| New Study Shows Long-Term Effects of Drug Prevention | 05-15-12 |
| HealthGovMatters-conferentie op 16 mei 2012 in Brussel | 05-15-12 |
| Debiopharm and Vifor Pharma Sign an Exclusive Agreement for the Distribution and Commercialization of Pamorelin®LA in Switzerland - A Drug Treatment for Prostate Cancer and Endometriosis | 05-15-12 |
| Inovio Pharmaceuticals to Present at SPI 2012 | 05-15-12 |
| New Executive Vice President Commercial Appointed | 05-15-12 |
| Wolters Kluwer Sells Its Healthcare Analytics Business to Symphony Technology Group (STG) | 05-14-12 |
| La conférence HealthGovMatters se déroulera le 16 mai 2012 à Bruxelles | 05-14-12 |
| CHPA Applauds Arizona's Adoption Of HB 2263 | 05-14-12 |
| Ampio Pharmaceuticals Schedules 2012 Update Webcast | 05-14-12 |
| Coping With New FDA Mandates For Drug Sample Distribution | 05-14-12 |
| myMatrixx Names Craig Rollins, Vice President of Ancillary and Business Development | 05-14-12 |
| Synchrogenix Opens in Sweden | 05-14-12 |
| Mylan lanceert Generiek Lipitor® in vijf Europese landen | 05-14-12 |
| The ALS Therapy Development Institute Partners with Neurotune to Investigate Potential Treatments for Motor Neuron Disease | 05-14-12 |
| Lilly Oncology To Disclose New Pipeline Data At ASCO 2012 | 05-14-12 |
| Mylan lance son générique du Lipitor® dans cinq pays européens | 05-14-12 |
| Pearl Therapeutics Phase 2b Twice-Daily Dosing Data Suggest Morning and Evening Benefit of PT003 in Patients with COPD | 05-14-12 |
| Piramal Healthcare presenta resultados positivos con su ensayo clínico pivotal de fase III para BST-CarGel® | 05-14-12 |
| Stiefel receives US FDA approval of Fabior? Foam, 0.1% | 05-11-12 |
| Failure to Take Medicine Linked to Unnecessary Hospital Visits, Especially for Medicare Patients Taking High Blood Pressure or High Cholesterol Medications | 05-11-12 |
| Depomed Announces Receipt of $1 million Milestone Payment From Ironwood Pharmaceuticals, Inc. | 05-11-12 |
| CORRECTION - Movianto GmbH: Movianto termina el nuevo centro de distribución europeo en los Países Bajos | 05-11-12 |
| Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars | 05-11-12 |
| Auxilium Pharmaceuticals, Inc. to Present At The BofAML 2012 Health Care Conference | 05-11-12 |
| Mylan Launches Generic Lipitor® in Five European Countries | 05-11-12 |
| Amakem Appoints Dr. Steve Pakola as Chief Medical Officer; Dr. George Lasezkay Joins Board of Directors | 05-11-12 |
| Pixuvri® von Cell Therapeutics in der Europäischen Union zugelassen zur Monotherapie mehrfach rezidivierter oder therapierefraktärer aggressiver Non-Hodgkin-B-Zell-Lymphome bei Erwachsenen | 05-10-12 |
| Pixuvri® de Cell Therapeutics approuvé dans l'Union Européenne comme monothérapie pour le traitement des patients adultes atteints de lymphome non hodgkinien à cellules B agressif multirécidivant ou réfractaire | 05-10-12 |
| Alexza Reports 2012 First Quarter Financial Results and Provides Business Update | 05-10-12 |
| Optimer Pharmaceuticals Reports First Quarter 2012 Financial Results | 05-10-12 |
| BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its First Quarter 2012 Financials | 05-10-12 |
| Cempra, Inc. Reports First Quarter 2012 Financial and Operating Results | 05-10-12 |
| ChromaDex® Announces Financial Results for the First Quarter 2012 | 05-10-12 |
| Star Scientific Files First-Quarter Financials; Reports Continuing Increase in Anatabloc® Sales | 05-10-12 |
| New Guidelines: Treatments Can Help Prevent Migraine | 05-10-12 |
| Cell Therapeutics' Pixuvri® Approved in European Union as Monotherapy to Treat Adult Patients with Multiply Relapsed or Refractory Aggressive Non-Hodgkin B-Cell Lymphomas | 05-10-12 |
| GrowthWorks Atlantic Venture Fund Converts Debenture into Common Shares of STI | 05-10-12 |
| Oxford Finance Provides $27.5 Million Debt Financing Facility to Pacira Pharmaceuticals | 05-10-12 |
| ULURU Inc. Announces Conference Call To Discuss Financial Results For The First Quarter Ended March 31, 2012 | 05-10-12 |
| MinuteClinic Opens Its First Walk-in Medical Clinics Inside CVS/pharmacy Stores in San Antonio | 05-10-12 |
| SOCMA's BPTF Welcomes House Committee Passage of FDA Reform Act | 05-10-12 |
| High Expectations for New U.S. Biosimilar Pharmaceuticals Following FDA Guidance Documents | 05-10-12 |
| CORRECTION - Bayer Animal Health: Garfield überwindet die Angst vor dem Tierarzt bei der Behandlung von Nierenleiden bei Katzen | 05-10-12 |
| New 126,000 Square Foot Lease at 650 East Kendall Street Signed By BioMed Realty | 05-10-12 |
| CVS Caremark Releases 2011 Corporate Social Responsibility Report | 05-10-12 |
| Depomed to Present at Bank of America Merrill Lynch 2012 Health Care Conference | 05-10-12 |
| Incline Therapeutics Announces Appointment of John Tucker as Chief Commercial Officer | 05-10-12 |
| Pharmacyclics Reports Fiscal 2012 Third Quarter Financial Results and Recent Developments | 05-10-12 |
| Oral Drug Delivery Market to 2017 - Out-licensing Proprietary Technologies for Proteins, Peptides and Small Molecules to Drive Revenue Growth | 05-10-12 |
| Morinda Bioactives Releases New Shield Biomedical Product Line | 05-10-12 |
| Innovations in Sports Nutrition : 29-30 May 2012 - Radisson Blu Portman Hotel, London | 05-10-12 |
| Inovio Pharmaceuticals Reports 2012 First Quarter Financial Results | 05-09-12 |
| WAISMANN METHOD® Medical Director Voices Support for Fibromyalgia Awareness Day | 05-09-12 |
| Savient Pharmaceuticals Completes Financing and Debt Restructuring Transactions | 05-09-12 |
| Chindex International, Inc. Reports Financial Results for the First Quarter of 2012 | 05-09-12 |
| Telik Announces First Quarter 2012 Financial Results | 05-09-12 |
| Dehaier Medical Announces 2012 First Quarter Financial Results | 05-09-12 |
| "Supermoms against Superbugs" in their own words | 05-09-12 |
| Janssen Research & Development Submits Supplemental New Drug Application to U.S. FDA for XARELTO® (rivaroxaban) to Reduce the Risk of Stent Thrombosis in Patients with Acute Coronary Syndrome | 05-09-12 |
| Watson Announces Formation of Global Integration Management Office to Support Pending Actavis Acquisition | 05-09-12 |
| Competitive Insights to Protein Kinase Therapeutics in Oncology: The Faster Route to Consider Your Options and Position of Others | 05-09-12 |
| U.S. Market for Diabetes Monitoring, Treatment and Drug Delivery 2012 | 05-09-12 |
| InnoPharma Inc. Appoints John C. Deighan as Chief Financial Officer | 05-09-12 |
| Halozyme Therapeutics to Present at the Bank of America Merrill Lynch 2012 Health Care Conference | 05-09-12 |
| Global API Market Analysis | 05-09-12 |
| Isis Pharmaceuticals to Present at the Bank of America Merrill Lynch 2012 Health Care Conference | 05-09-12 |
| BioDelivery Sciences to Present at the Bank of America Merrill Lynch 2012 Healthcare Conference | 05-09-12 |
| Savient Pharmaceuticals Reports First Quarter 2012 Financial Results | 05-09-12 |
| ZyGEM Signs OEM Agreement to Incorporate Its Breakthrough RNA Extraction Technology Into Quanta BioSciences' Kits for Quantitative PCR | 05-09-12 |
| Simcere Pharmaceutical Group Reports Unaudited First Quarter 2012 Results | 05-09-12 |
| ArcDia raises ? 2.7 million to Expand Multianalyte Point-of-Care Respiratory Tract Diagnostic Test | 05-09-12 |
| Delcath Highlights First Quarter 2012 And Recent Accomplishments | 05-08-12 |
| China Biologic Products Reports Higher Results for the First Quarter 2012 | 05-08-12 |
| The Midwest Prepares to 'Tackle Gnats' with an Unlikely Weapon | 05-08-12 |
| PDR and the iHealth Alliance Announce New Drug Safety Certification for EHRs | 05-08-12 |
| Generex Announces Presentations of Antigen Express AE37 Breast Cancer Vaccine Data at ASCO 2012 | 05-08-12 |
| Life Extension Foundation® study finds Cognitex® with NeuroProtection Complex may provide a positive impact on cognitive performance | 05-08-12 |
| Roskamp Institute Reports Beneficial Effects of Nutritional Supplementation with Anatabine in an Animal Model of Multiple Sclerosis | 05-08-12 |
| AMCC Launches First In the Nation Prescription Drug Prevention Mobile App | 05-08-12 |
| Survey Shows eContent Critical to Corporate Strategies | 05-08-12 |
| Inaugural Harris Poll Physician Pulse(SM) Study: Viagra® and Cialis® are Highest Ranked in Trust | 05-08-12 |
| Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year EPS Guidance | 05-08-12 |
| New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline | 05-08-12 |
| Data from Study of Elderly Depressed Patients are Reported for Investigational Compound Lu AA21004 on Symptoms of Major Depressive Disorder (MDD) | 05-08-12 |
| Marshall Edwards Receives $4 Million Subscription From Novogen In Rights Offering | 05-08-12 |
| Novogen Board Approves US$4 Million Investment In Marshall Edwards Rights Offering | 05-08-12 |
| Neuralstem Updates ALS Stem Cell Trial Progress | 05-08-12 |
| Par Pharmaceutical Companies Reports First Quarter 2012 Results | 05-08-12 |
| AcelRx Pharmaceuticals Reports First Quarter 2012 Financial Results | 05-08-12 |
| Data Presented at the American Psychiatric Association Annual Meeting Supports Gender-Specific Dosing of Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV | 05-08-12 |
| RxAlly Expands National Network With Addition Of Nineteen Community Pharmacy Organizations Representing Over 2,000 Pharmacies | 05-08-12 |
| Amakem Presents AMA0076 Data at the 2012 ARVO Annual Meeting | 05-08-12 |
| Sativex® gjensidig anerkjennelsesprosedyre med anbefaling for godkjenning i ti europeiske land | 05-08-12 |
| Sativex® procedur för ömsesidigt godkännande avslutas med rekommendation om godkännande i tio europeiska länder | 05-08-12 |
| Regeneron and Bayer Announce Co-Promotion Agreement With Santen For EYLEA® (aflibercept) Injection in Japan | 05-08-12 |
| Gegenseitiges Anerkennungsverfahren für Sativex® schließt mit der Empfehlung für die Zulassung in zehn europäischen Ländern | 05-08-12 |
| Mindray Medical to Acquire Controlling Stake in Hangzhou Optcla Medical Instrument | 05-07-12 |
| Halozyme Reports First Quarter 2012 Financial Results | 05-07-12 |
| Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion Settlement with Abbott Laboratories Over Off-Label Marketing of Antiepileptic Medication Depakote | 05-07-12 |
| Safe Use of Acetaminophen | 05-07-12 |
| Abbott Reaches Settlement Agreement on Depakote | 05-07-12 |
| Edens RX Announces Discount For Military Personnel | 05-07-12 |
| Pennsylvania Puts Additional 20 Drug Recognition Experts on the Road | 05-07-12 |
| Rituximab Promotes Long-Term Response for Patients with Immune Destruction of Platelets | 05-07-12 |
| Provectus Pharmaceuticals, Inc.'s Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com | 05-07-12 |
| PharmacyGPO Buying Group Selects H. D. Smith as Primary National Distributor | 05-07-12 |
| New Reproductive Support Dietary Supplement, Pregnitude?, Now Available For Women Having Difficulty Conceiving | 05-07-12 |
| BioSpecifics Technologies Corp. Announces Rescheduled First Quarter 2012 Financial Results Conference Call to May 10, 2012 | 05-07-12 |
| Statin Users Suffering from Side Effects Are in the Dark | 05-07-12 |
| Dehaier Medical to Report First Quarter 2012 Financial Results on May 9th, 2012 | 05-07-12 |
| Keryx Biopharmaceuticals Announces Reversion of KRX-0401 (Perifosine) License Rights to Aeterna Zentaris | 05-07-12 |
| H. D. Smith Signs Three Year Prime Vendor Agreement with PharmacyGPO Buying Group | 05-07-12 |
| Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Alexza Pharmaceuticals Inc. | 05-07-12 |
| ADVENTRX Reports First Quarter 2012 Financial Results | 05-07-12 |
| New Educational Resource Helps Healthcare Professionals Recognize, Address Substance Abuse in Clinical Practice Settings | 05-07-12 |
| AssureRx Health Launches Personalized Medicine Test for ADHD | 05-07-12 |
| National Stakeholders Meet To Consider Improvements In Antimicrobial Use In Food Animal Production | 05-07-12 |
| Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods | 05-07-12 |
| BioElectronics' ActiPatch Reduces Muscle Soreness in Runners | 05-07-12 |
| Ocular Therapeutix Commences a Sustained Release Travoprost Punctum Plug Feasibility Study for Treatment of Glaucoma | 05-05-12 |
| Staffing and Performance Benchmarks for Quality Function Highlight New Medical Device Study | 05-04-12 |
| Amgen to Present at the Baird Growth Stock Conference | 05-04-12 |
| Watson to Present at the Bank of America Merrill Lynch 2012 Health Care Conference | 05-04-12 |
| Breckenridge signs Generic Agreement with Zhejiang Huahai Pharmaceuticals Co., Ltd. | 05-04-12 |
| Innophos To Present At 2012 Oppenheimer Industrials Conference | 05-04-12 |
| Endo to Present at Bank of America Merrill Lynch 2012 Health Care Conference | 05-04-12 |
| Herborium Announces Continuing Progress In Key Strategic Initiatives | 05-04-12 |
| Shire to Present Scientific Data Across Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting May 5-9 | 05-04-12 |
| Express Scripts to Present at Bank of America Merrill Lynch Conference | 05-04-12 |
| Kmart® Launches New Pet Prescription Program And Purina® Treat Giveaway | 05-04-12 |
| Aperture Health, Inc. focuses in on IV Therapy Value Creation and the Merger and Acquisition Activities in the Home Infusion Therapy Sector. | 05-04-12 |
| Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with Hypertriglyceridemia | 05-04-12 |
| ResearchMoz: Global and China 4A Zeolite Industry 2012 Deep Research Report - Market Research Report | 05-04-12 |
| Pharmaceutics International, Inc. (Pii) Supports University Pharmaceutical Technology Education and Research | 05-03-12 |
| Larry Flynt Argues for the Legalization of Marijuana | 05-03-12 |
| Alexza Receives Complete Response Letter for Adasuve? NDA | 05-03-12 |
| Washington State Medical Association (WSMA) Urges Adults to Get Recommended Immunizations | 05-03-12 |
| CSL Behring Initiates Study of Subcutaneous Administration of C1-esterase Inhibitor in Patients with Hereditary Angioedema | 05-03-12 |
| Savient Pharmaceuticals to Present at the Bank of America Merrill Lynch 2012 Health Care Conference | 05-03-12 |
| DURECT Corporation Announces First Quarter 2012 Financial Results and Update of Programs | 05-03-12 |
| Sequenom, Inc. Reports Financial Results For The First Quarter Of 2012 | 05-03-12 |
| Cumberland Pharmaceuticals Reports First Quarter 2012 Financial Results | 05-03-12 |
| Rethinking Research Ethics: Carnegie Mellon and McGill Researchers Challenge Post-marketing Trial Practices | 05-03-12 |
| Lilly Applauds Law Enforcement Officials for their Successful Investigation and Recovery of Pharmaceuticals Stolen from Connecticut Distribution Center | 05-03-12 |
| Bayer Employees Named Rising Stars by Healthcare Businesswomen's Association | 05-03-12 |
| Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community | 05-03-12 |
| Telemedicine Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018 | 05-03-12 |
| CPhI promueve Road Show para la industria farmacéutica en Chile | 05-03-12 |
| CPhI promove Road Show para indústria farmacêutica no Chile | 05-03-12 |
| Abbott to Acquire Action Pharma's Investigational Compound, AP214, in Phase 2b Development for Prevention of Acute Kidney Injury | 05-03-12 |
| Optimer Pharmaceuticals to Present at the Bank of America Merrill Lynch 2012 Health Care Conference | 05-03-12 |
| Boehringer Ingelheim Announces Launch of GLORIA?-AF Registry in Newly-Diagnosed Patients with Non-Valvular Atrial Fibrillation | 05-03-12 |
| GP Strategies Reports Strong First Quarter 2012 EPS of $0.23 | 05-03-12 |
| Cempra, Inc. to Report First Quarter 2012 Financial and Operating Results, and Host Conference Call and Webcast on May 10, 2012 | 05-03-12 |
| DURECT Announces Issuance of U.S. Patents Covering ORADUR® Technology | 05-03-12 |
| Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical | 05-03-12 |
| Neuland Labs Reports Financial Results For Fiscal Year 2012 | 05-03-12 |
| Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market | 05-03-12 |
| Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio | 05-03-12 |
| Emergency Aid Shipment for Haiti Cholera Epidemic | 05-02-12 |
| Covance Reports First Quarter Net Revenue Growth Of 5.7% To $531M, EPS Of $0.60, And Adjusted Net Orders Of $704M | 05-02-12 |
| Genomic Health Announces First Quarter 2012 Financial Results and Business Progress | 05-02-12 |
| Omega Protein Announces First Quarter Fiscal 2012 Financial Results | 05-02-12 |
| Covance Announces Executive Appointments | 05-02-12 |
| Omnicell Announces First Quarter 2012 Results | 05-02-12 |
| Nektar Therapeutics Reports Financial Results for the First Quarter of 2012 | 05-02-12 |
| Abbott to Present at Deutsche Bank 37th Annual Health Care Conference | 05-02-12 |
| Yaz and Yasmin Litigants Offered Settlement Funding by RD Legal Funding | 05-02-12 |
| Buying Asthma Medication Online Can be Safe and Affordable | 05-02-12 |
| Global Pharmaceutical Leaders All Converging in Parsippany, New Jersey on September 11-12, 2012 for Breakthrough Event | 05-02-12 |
| Simbionix Introduced its Next Generation Simulator Platform for Endovascular Training | 05-02-12 |
| Simbionix presenta su plataforma de simulación de próxima generación para la formación endovascular | 05-02-12 |
| Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism | 05-02-12 |
| Simbionix présente sa plateforme de simulation de nouvelle génération pour la formation aux interventions endovasculaires | 05-02-12 |
| Endocrinology Market to 2018 - Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients | 05-02-12 |
| New Ameritox Rx Guardian INSIGHT(SM) Report Supports Improved Patient Care, Public Safety | 05-02-12 |
| OTC Pharmaceuticals: Global Industry Almanac, MarketLine | 05-02-12 |
| Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro? for Treatment of Chronic Pain | 05-02-12 |
| Sanofi iBGStar® Blood Glucose Monitoring System Now Available in the U.S. | 05-02-12 |
| Echo Therapeutics Announces Positive Clinical Trial Results of Symphony® tCGM System | 05-02-12 |
| Biodel's Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office | 05-02-12 |
| Omeros to Present at Deutsche Bank Securities Health Care Conference | 05-02-12 |
| CVS Caremark Reports Record First Quarter Results | 05-02-12 |
| Ophthalmic Drugs: World Market Prospects 2012-2022 | 05-02-12 |
| National Study: Teen "Heavy" Marijuana Use Up 80 Percent Since 2008, One in Ten Teens Reports Using Marijuana at Least 20 Times a Month | 05-02-12 |
| Sunpeaks Ventures Files Defamation Lawsuit | 05-01-12 |
| Vessix ontvangt CE-markering voor het V2 Renal Denervation System? ter behandeling van hypertensie | 05-01-12 |
| Vessix obtient le marquage CE pour son système de dénervation rénale V2 Renal Denervation System? pour le traitement de l'hypertension | 05-01-12 |
| National Patient Advocate Foundation Praises Signing of the Delaware Cancer Treatment Access Act into Law | 05-01-12 |
| Michael J. Fox Foundation-Funded Study Identifies Best Dyskinesia Clinical Rating Scale | 05-01-12 |
| Vessix erhält CE-Kennzeichnung für V2 Renal Denervation System? zur Behandlung von Bluthochdruck | 05-01-12 |
| Diabecline Antibiotic Receives Edison Award for Best New Pharmaceutical Product | 05-01-12 |
| Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine | 05-01-12 |
| University Hospitals Case Medical Center's Harrington Discovery Institute Launches Grant Program to Accelerate Drug Discovery and Development | 05-01-12 |
| SCOLR Pharma Welcomes Clem Calabrese as Director of Field Sales | 05-01-12 |
| Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease | 05-01-12 |
| Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine | 05-01-12 |
| MDHI in Agreement with Debt Holders - Portion of Convertible Debt and Additional 14M Warrants Cancelled -- Total of 101M Warrants Cancelled this Year | 05-01-12 |
| Acella Pharmaceuticals Announces a New Addition to the Commercial Team | 05-01-12 |
| CVS/pharmacy Mobile App Transforms Smartphones into Digital ExtraCare Cards | 05-01-12 |
| Avanir Pharmaceuticals Announces Date Of Fiscal 2012 Second Quarter Financial Results And Conference Call | 05-01-12 |
| Northwest Bio Awarded $5.5 Million German Government Grant | 05-01-12 |
| Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel | 05-01-12 |
| Envy Medical, Inc. Announces Publication of Lumixyl Study in the April 2012 Journal of Cosmetic Laser Medicine | 05-01-12 |
| Rigel Announces First Quarter 2012 Financial Results | 05-01-12 |
| Hospira Reports First-Quarter 2012 Results | 05-01-12 |
| Vessix Receives CE Mark For V2 Renal Denervation System? For Treatment Of Hypertension | 05-01-12 |
| QIAGEN and Cardinal Health Collaborate to Offer Molecular Diagnostic Products to Smaller and Mid-sized U.S. Hospitals | 04-30-12 |
| Wellfount Pharmacy Exhibits Talyst Products at OCHA/OCAL 2012 | 04-30-12 |
| Eisai Inc. Announces Appointment Of Senior Vice President And General Counsel, Allen Waxman | 04-30-12 |
| Stronger! INTAC? formulation technology protects intended action of extended release drugs | 04-30-12 |
| Valeant Pharmaceuticals To Webcast 2012 Annual Meeting Of Shareholders | 04-30-12 |
| Protein Sciences Strengthens its Senior Management with Leaders in Manufacturing and Finance | 04-30-12 |
| New research expands understanding of psychoactive medication use among children in foster care | 04-30-12 |
| StarCap 1500® Co-Processed Starch Excipient Receives Pharmaceutical Precedence of Use in the European Union | 04-30-12 |
| Millennium Laboratories Commends Florida's Governor Scott For Strengthening Regulation of Clinical Laboratories | 04-30-12 |
| Voraxaze® (glucarpidase) Launched in the US | 04-30-12 |
| PreCision Dermatology Acquires Assets of Triax Pharmaceuticals | 04-30-12 |
| Sangamo BioSciences Nominates Saira Ramasastry To The Company's Board Of Directors | 04-30-12 |
| Trovagene Announces Validation Program for Trans-Renal K-RAS Mutation Detection in Pancreatic Cancer | 04-30-12 |
| Catheters Market Research Reports & Catheters Industry Analysis - 35 Premium Reports Available on Catheters Market Covering Industry Size, Share, Growth, Strategies, Insights, Company Profiles, SWOT Analysis and Forecasts: ResearchMoz | 04-30-12 |
| Haemonetics Signs Definitive Agreement To Acquire Hemerus Medical, LLC | 04-29-12 |
| PDL BioPharma to Announce First Quarter 2012 Financial Results on May 3, 2012 | 04-27-12 |
| Watson adquirirá a Actavis Group por 4,25 mil millones de euros | 04-27-12 |
| MetaStat, Inc. Executes Two New Licenses | 04-27-12 |
| Valeant Pharmaceuticals to Present at Deutsche Bank Securities, Inc. 37th Annual Health Care Conference | 04-27-12 |
| More Jobs, More Life Science Research, More Prosperity for Canada: Rx&D urges Canada to complete CETA agreement with the EU | 04-27-12 |
| Watson vai adquirir Grupo Actavis por EUR 4,25 bilhões | 04-27-12 |
| Millennium Laboratories Sponsors Educational Programs in Support of Safe Prescribing Practices at Regional Pain Society Conferences | 04-27-12 |
| Watson adquiere Actavis Group por 4.250 millones de euros | 04-27-12 |
| Sanofi: Strong performance in Q1 2012 including Genzyme contribution | 04-27-12 |
| Pharmaxis obtient l'autorisation de mise sur le marche de Bronchitol dans l'Union Europeenne | 04-27-12 |
| Rapport sur la solubilité de Pharma IQ | 04-27-12 |
| Pharmaxis recibe la aprobación para la comercialización de Bronchitol en la UE | 04-27-12 |
| Pharam-IQ-Löslichkeitsreport | 04-27-12 |
| Pharma IQ's Solubility Report | 04-27-12 |
| Pharmaxis riceve l'approvazione alla commercializzazione di Bronchitol in Europa | 04-27-12 |
| Novartis drug Afinitor® approved by FDA as first medication to treat patients with non-cancerous kidney tumors associated with TSC | 04-26-12 |
| Video: Watson adquiere Actavis Group por 4.250 millones de euros | 04-26-12 |
| Toss Them, Flush Them, Hang On To Them: Survey Finds Surprises When It Comes To Prescription Medications | 04-26-12 |
| Unilife Corporation Announces Financial Results For Fiscal Year 2012 Third Quarter | 04-26-12 |
| Vidéo : Watson près de racheter le groupe Actavis à 4,25 milliards EUR | 04-26-12 |
| Hospira to Present at the Bank of America Merrill Lynch 2012 Health Care Conference | 04-26-12 |
| Video: Watson plant Übernahme von Actavis Group für 4,25 Mrd. Euro | 04-26-12 |
| Interim results of VITOBA? (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology | 04-26-12 |
| CHPA Applauds Alabama's Adoption Of HB 363 | 04-26-12 |
| Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate | 04-26-12 |
| International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets. | 04-26-12 |
| Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study | 04-26-12 |
| Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter | 04-26-12 |
| Rock Creek Pharmaceuticals Announces First Study Using Anatabloc® Nutritional Supplementation in Alzheimer's Patients | 04-26-12 |
| New Clinical Endocrinology Guidelines Support Lp-PLA2 Measurement For Risk Assessment of Coronary Artery Disease | 04-26-12 |
| QRxPharma's US Commercialisation Partner, Actavis, to be acquired by Watson Pharmaceuticals, Inc.: MoxDuo® IR on track for launch in Q3, 2012 | 04-26-12 |
| Galenea to Receive $6 Million From The Stanley Medical Research Institute to Progress Pro-Cognitive Drug Discovery and Development Program | 04-26-12 |
| Transcept Prices Public Offering of Common Stock | 04-26-12 |
| United Therapeutics Corporation Reports First Quarter 2012 Financial Results | 04-26-12 |
| Clinical Trial Highlights Positive Oncoprex Results in Lung Cancer Patients | 04-26-12 |
| Watson acquiert le groupe Actavis pour 4,25 Milliards d'Euros | 04-26-12 |
| PRA annonce avoir établi une relation stratégique avec Amgen | 04-26-12 |
| Takeda Receives Complete Response Letter from the FDA for Type 2 Diabetes Investigational Therapies Alogliptin and Fixed-Dose Combination Alogliptin and Pioglitazone | 04-26-12 |
| Lexicon to Provide First Quarter 2012 Financial Results | 04-25-12 |
| Med Ad News Honors Healthcare Communication Agencies at 23rd Annual Manny Awards | 04-25-12 |
| WAISMANN METHOD® Director Encourages Public to Participate in National Take-Back Day | 04-25-12 |
| Watson to Acquire Actavis Group for EUR4.25 Billion | 04-25-12 |
| Video: Watson to Acquire Actavis Group for EUR4.25 Billion | 04-25-12 |
| DURECT Corporation Invites You to Join its First Quarter 2012 Earnings Conference Call | 04-25-12 |
| Icahn Issues Statement Regarding Amylin Pharmaceuticals | 04-25-12 |
| DiversityInc Names Lilly a Top Company for Diversity | 04-25-12 |
| Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters | 04-25-12 |
| Southern Research Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings | 04-25-12 |
| Leica Biosystems erhält FDA-Zulassung für sein vollautomatisches Bond Oracle? HER2 IHC-System auf Leica BOND-MAX | 04-25-12 |
| Neuralstem Chief Scientific Officer To Present At Spinal Cord Injury Conference In China | 04-25-12 |
| Blue Cross Blue Shield of Michigan and Blue Care Network support the Drug Enforcement Administration's Nationwide Prescription "Drug Take-Back Day" | 04-25-12 |
| The Scleroderma Foundation's Walk for Cure Campaign asks you to take the "Benner Challenge" | 04-25-12 |
| New Products from Abbott's EAS® Sports Nutrition Brand Help Athletes Improve Post-Workout Recovery and Meet Fitness Goals | 04-25-12 |
| Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets | 04-25-12 |
| Webcast Alert: Isis Pharmaceuticals' First Quarter 2012 Financial Results Conference Call | 04-25-12 |
| Leica Biosystems reçoit l'approbation de la FDA pour son système IHC entièrement automatisé de contrôle de l'HER2 Bond Oracle? sur le Leica BOND-MAX | 04-25-12 |
| Lilly Reports Solid Start to the Year With First-Quarter 2012 Results, Raises EPS Guidance | 04-25-12 |
| BioElectronics' Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals | 04-25-12 |
| Pfizer Outlines Common Pitfalls Leading to Prosecution in the Pharma Industry | 04-25-12 |
| Pfizer umreißt typische Fallstricke, die zur Strafverfolgung in der Pharmaindustrie führen können | 04-25-12 |
| Pfizer présente les écueils courants pouvant conduire à des poursuites judiciaires dans l'industrie pharmaceutique | 04-25-12 |
| Boehringer Ingelheim Standardizes All Prescription Medicine Commercial Teams Worldwide on Cloud-Based, Veeva CRM and iRep | 04-25-12 |
| Thomson Reuters lance une nouvelle solution mobile d'aide à la prise de décision en oncologie en faveur des dirigeants en Recherche et Développement pharmaceutique | 04-25-12 |
| The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Ardea Biosciences, Inc. in Connection with the Sale of the Company to AstraZeneca | 04-24-12 |
| PuraMed BioScience, Inc.,® Continues to Build Awareness for LipiGesic® M Through Media Campaigns | 04-24-12 |
| RainTree Oncology Services Closes $11.1 Million in Second Round Financing | 04-24-12 |
| PA State Police to Accept Expired, Unwanted Prescription Drugs | 04-24-12 |
| Upsher-Smith Expands Epilog.us With Addition Of Expert Opinion On Epilepsy & Comorbidities | 04-24-12 |
| Soy-Based S-equol Supplement Reduces Hot Flash Frequency, Muscle And Joint Pain In U.S. Postmenopausal Women | 04-24-12 |
| Perrigo Company Will Release Third Quarter Fiscal 2012 Results On May 8, 2012 | 04-24-12 |
| MediPendant? to Return to Television on May 20th New Television Campaign - Company Provides MediPendant? Update | 04-24-12 |
| Fuse Science Partners With GNC To Open National Distribution Of EnerJel? | 04-24-12 |
| American Academy of Family Physicians Foundation Launches Cities for Life | 04-24-12 |
| Watching, Reading and Listening: A New Way to Interact with Patient Information | 04-24-12 |
| Structural Trends to Profoundly Change Life Sciences Industry, Genpact Study Shows | 04-24-12 |
| Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012 | 04-24-12 |
| Mylan Launches Generic Version of Zyprexa® Tablets | 04-24-12 |
| Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center | 04-24-12 |
| Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement | 04-24-12 |
| Cetero Reaches Final Resolution with the Food and Drug Administration | 04-24-12 |
| SMT C1100 For Duchenne Muscular Dystrophy Moves To Human Testing | 04-24-12 |
| Merck annonce ses plans pour la réorganisation de Merck Serono en Suisse | 04-24-12 |
| Merck kündigt Implementierungspläne für Merck Serono in der Schweiz im Rahmen des Effizienzsteigerungsprogramms an | 04-24-12 |
| Medical Korea, Opening New Prospects in the Global Healthcare Industry | 04-24-12 |
| Shengtai Pharmaceutical, Inc. Establishes Special Committee to Evaluate Non-binding Going Private Proposal | 04-24-12 |
| Alexza to Announce 2012 First Quarter Financial Results on Thursday, May 10, 2012 | 04-23-12 |
| Shingles Vaccine is Safe, According to New Study | 04-23-12 |
| Academy of Managed Care Pharmacy (AMCP) Installs 2012-2013 Board of Directors | 04-23-12 |
| Asubio Initiates Landmark Clinical Study in Spinal Cord Injury | 04-23-12 |
| Ultragenyx Relocates Company Headquarters to Support Operational Expansion | 04-23-12 |
| Delcath Systems, Inc. Secures $20 Million Credit Facility | 04-23-12 |
| MicuRx Pharmaceuticals Completes Phase 1 Trial For MRX-I, A Next-Generation Antibiotic | 04-23-12 |
| Dr. Mukesh Batra Awarded Padma Shri for Medicine | 04-23-12 |
| U.S. Census Bureau Daily Feature for April 22 | 04-22-12 |
| Sunpeaks Ventures Provides Corporate Update | 04-21-12 |
| Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm | 04-20-12 |
| Pharmaceutical Industry Service Company Awarded The UK's Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade | 04-20-12 |
| Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012 | 04-20-12 |
| Santaris Pharma A/S præsenterer de endelige Fase 2a-undersøgelsesresultater for miravirsen, der viser dosisafhængig, langtidsvirkende antiviral aktivitet hos patienter med Hepatitis C | 04-20-12 |
| WuXi PharmaTech Files 2011 Annual Report on Form 20-F | 04-20-12 |
| Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector | 04-20-12 |
| China Shenghuo Announces Receipt of Deficiency Notice and Voluntary Delisting from NYSE Amex LLC and Deregistration with the SEC | 04-20-12 |
| New Neupro® Data in Parkinson's Disease and Restless Legs Syndrome to be Presented at the 64th American Academy of Neurology Annual Meeting | 04-20-12 |
| Clinical Trial at Evergreen Healthcare Shows Intestinal Gel Reduces Symptoms of Advanced Parkinson's Disease | 04-20-12 |
| CVS Caremark Corporation to Hold First Quarter 2012 Conference Call | 04-20-12 |
| CHPA Applauds Alabama Senate's Passage of Anti-Meth Bill | 04-20-12 |
| Ameritox Files Amended Complaint Against Millennium Laboratories For Injunctive Relief, Declaratory Relief and Damages | 04-20-12 |
| Nutrilys Del Mar Joins Health Forces With LAPD Underwater Dive Unit | 04-20-12 |
| Abbott Receives U.S. FDA Clearance to Use iFS Advanced Femtosecond Laser Technology for Arcuate Incisions in Cataract Surgery | 04-20-12 |
| VeriStrat® Test Results Correlate with Survival Outcomes in Advanced Lung Cancer | 04-20-12 |
| Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments | 04-20-12 |
| Watson to Host Conference Call and Webcast to Discuss First Quarter 2012 Earnings | 04-20-12 |
| Présentations de nouvelles données par Merck Serono sur la sclérose en plaques lors du 64e Congrès Annuel de l'American Academy of Neurology | 04-20-12 |
| Merck Serono präsentiert neue Daten zu Multipler Sklerose beim 64. Jahrestreffen der amerikanischen Akademie für Neurologie | 04-20-12 |
| Eisai Amends License Agreement With Teikoku Pharma USA For Aricept® Patch (Donepezil Transdermal System) | 04-20-12 |
| American Oriental Bioengineering Announces Undergoing SFDA Directed Inspection of Capsules | 04-20-12 |
| La recherche en biologie moléculaire accélérée grâce à la synthèse rapide de gènes de GenScript | 04-19-12 |
| GenScript treibt die molekularbiologische Forschung mit Rush Gene Synthesis weiter voran | 04-19-12 |
| Watson Launches Generic FORTAMET(R) | 04-19-12 |
| Amgen Announces Webcast of 2012 First Quarter Financial Results | 04-19-12 |
| Par Pharmaceutical Acquires Rights to Market and Distribute Generic Dexilant® in the U.S. | 04-19-12 |
| Cardinal Health Foundation Invites Local Non-profit Organizations To Apply For Grants To Prevent Prescription Drug Abuse | 04-19-12 |
| GPhA Enlists IMS Health to Further Address Drug Shortage Crisis | 04-19-12 |
| Study Finds Generic Drug Discount Programs Requiring Membership May Result in Incomplete PBM and Health Plan Data | 04-19-12 |
| AMCP, FMCP Recognize Outstanding Members at Annual Awards Dinner | 04-19-12 |
| Abbott Presents Positive Results from Phase 2 "Pilot" Study of an Interferon-Free Combination Regimen for the Treatment of Hepatitis C | 04-19-12 |
| BOTOX® Cosmetic (onabotulinumtoxina) Celebrates 10-year Anniversary Searching For "Women Just Like You" To Be Featured In An Advertisement In PEOPLE® Magazine | 04-19-12 |
| Rueda de prensa y emisión web de Resverlogix de anuncio de la plataforma de mecanismo de acción | 04-19-12 |
| Ameritox Counters Competitor's Misleading Statements | 04-19-12 |
| Watson Confirms Glumetza® Patent Challenge | 04-19-12 |
| Specialty pharmacy utilization management proves effective | 04-19-12 |
| Sanofi and Michael J. Fox Foundation Collaborate on Potential New Treatment for Parkinson's Disease | 04-19-12 |
| Phase 2b Data Show SVR12 in Cirrhotic HCV Patients Treated with Interferon-Free Regimen | 04-19-12 |
| Phase 2b Study of Boehringer Ingelheim's Interferon-Free Hepatitis C Treatment Shows Undetectable Virus in HCV Genotype-1 Patients 12 Weeks After Treatment Ended (SVR12) | 04-19-12 |
| Dengue Mosquitoes in Film Debut | 04-19-12 |
| Santaris Pharma A/S presents final Phase 2a study results for miravirsen showing dose-dependent, prolonged antiviral activity in Hepatitis C patients | 04-19-12 |
| AMCP's 24th Annual Meeting & Expo Opens in San Francisco | 04-19-12 |
| CrystalGenomics Announces Positive Results from Phase 2b Osteoarthritis Study of CG100649 | 04-19-12 |
| Cell Therapeutics, Inc. (CTI) to Host Conference Call April 19, 8:30 AM ET | 04-19-12 |
| U.S. FDA Clears Bayer HealthCare's CONTOUR® Next EZ Blood Glucose Monitoring System | 04-18-12 |
| Packaging therapeutic RNAs for targeted treatment of breast cancer | 04-18-12 |
| Genetic testing for new warfarin patients is rare, but often inappropriate | 04-18-12 |
| Webcast Alert: Isis Pharmaceuticals Holds Webcast to Discuss Clinical Development Plans for ISIS-APOCIIIRx | 04-18-12 |
